General Information of Disease (ID: DISXV8FG)

Disease Name Myelopathy
Synonyms myelopathy; spinal cord disorder; spinal cord disease or disorder; spinal cord disease; disorder of spinal cord; disease or disorder of spinal cord; disease of the spinal cord; disease of spinal cord
Disease Class 8B42: Myelopathy
Definition A disease involving the spinal cord.
Disease Hierarchy
DISWD40R: Disease
DISEP2HK: Central and peripheral nervous disease
DISXV8FG: Myelopathy
ICD Code
ICD-11
ICD-11: 8B42
Disease Identifiers
MONDO ID
MONDO_0002545
MESH ID
D013118
UMLS CUI
C0037928
MedGen ID
11550
HPO ID
HP:0002196
SNOMED CT ID
48522003

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
dequalinium DMXM19W Clinical trial Small molecular drug [1]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 10 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
ADA TTLP57V Strong Biomarker [2]
APP TTE4KHA Strong Biomarker [3]
CNTN2 TT2Z1WB Strong Altered Expression [4]
IL18RAP TTZUJVE Strong Genetic Variation [5]
MBP TT2RY5P Strong Biomarker [6]
MTHFR TTQWOU1 Strong Genetic Variation [7]
PTPN13 TT405FP Strong Altered Expression [8]
RNPEP TTD74YX Strong Biomarker [9]
SERPINH1 TTPSWQG Strong Biomarker [10]
SLC25A4 TTU5A6Q Strong Biomarker [11]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 DTT(s)
This Disease Is Related to 2 DTP Molecule(s)
Gene Name DTP ID Evidence Level Mode of Inheritance REF
ABCD1 DTKM9DZ Strong Biomarker [12]
SLC25A6 DTLMGFJ Strong Biomarker [11]
------------------------------------------------------------------------------------
This Disease Is Related to 8 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
ATF7IP OTU6ZA7F Strong Biomarker [13]
BTD OTJYTQ69 Strong Biomarker [14]
DPYSL5 OT6F9T6F Strong Biomarker [15]
NRSN1 OT1KKXC8 Strong Biomarker [16]
RAB4A OT7BL9WW Strong Biomarker [17]
TMED2 OTBLO7RW Strong Biomarker [16]
TMTC1 OTZ7NW96 Strong Biomarker [18]
AMN OTS1TJXG Definitive Genetic Variation [19]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 DOT(s)

References

1 Pharmacological characterisation of the human small conductance calcium-activated potassium channel hSK3 reveals sensitivity to tricyclic antidepressants and antipsychotic phenothiazines. Neuropharmacology. 2001 May;40(6):772-83.
2 The activity of adenosine deaminase and the level of nitric oxide in spinal cord of methotrexate administered rats: protective effect of caffeic acid phenethyl ester.Toxicology. 2006 Feb 1;218(2-3):125-33. doi: 10.1016/j.tox.2005.10.014. Epub 2005 Dec 2.
3 Methotrexate-related nonnecrotizing multifocal axonopathy detected by beta-amyloid precursor protein immunohistochemistry.Arch Pathol Lab Med. 2002 Jan;126(1):79-81. doi: 10.5858/2002-126-0079-MRNMAD.
4 Human T-lymphotropic virus type I-associated myelopathy and tax gene expression in CD4+ T lymphocytes.Ann Neurol. 1996 Jul;40(1):84-90. doi: 10.1002/ana.410400114.
5 Role of APOE and IL18RAP gene polymorphisms in cervical spondylotic myelopathy in Indian population.J Clin Neurosci. 2019 Aug;66:83-86. doi: 10.1016/j.jocn.2019.05.017. Epub 2019 May 21.
6 Critical role for PAR1 in kallikrein 6-mediated oligodendrogliopathy.Glia. 2013 Sep;61(9):1456-70. doi: 10.1002/glia.22534. Epub 2013 Jul 8.
7 Reversible nitrous oxide myelopathy and a polymorphism in the gene encoding 5,10-methylenetetrahydrofolate reductase.Br J Anaesth. 2006 Feb;96(2):222-5. doi: 10.1093/bja/aei300. Epub 2005 Dec 16.
8 Expression of FAP-1 (Fas-associated phosphatase) and resistance to Fas-mediated apoptosis in T cell lines derived from human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients.AIDS Res Hum Retroviruses. 1998 Feb 10;14(3):261-7. doi: 10.1089/aid.1998.14.261.
9 Utility of the central motor conduction time recorded from the abductor pollicis brevis and the abductor digiti minimi muscles in patients with C6-7 myelopathy.J Spinal Cord Med. 2018 Mar;41(2):182-191. doi: 10.1080/10790268.2017.1322673. Epub 2017 May 17.
10 Establishment and characterization of an HTLV-I cell line from a Taiwanese patient with HTLV-I-associated myelopathy.J Neurol Sci. 1993 Dec 1;120(1):46-53. doi: 10.1016/0022-510x(93)90023-r.
11 Two-level cervical corpectomy-long-term follow-up reveals the high rate of material failure in patients, who received an anterior approach only.Neurosurg Rev. 2019 Jun;42(2):511-518. doi: 10.1007/s10143-018-0993-6. Epub 2018 Jun 18.
12 Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy.Hum Mol Genet. 2008 Jun 15;17(12):1762-73. doi: 10.1093/hmg/ddn085. Epub 2008 Mar 14.
13 Low genetic diversity of the Human T-cell Lymphotropic Virus (HTLV-1) in an endemic area of the Brazilian Amazon basin.PLoS One. 2018 Mar 20;13(3):e0194184. doi: 10.1371/journal.pone.0194184. eCollection 2018.
14 Profound biotinidase deficiency in a child with predominantly spinal cord disease.J Child Neurol. 2008 Sep;23(9):1043-8. doi: 10.1177/0883073808318062. Epub 2008 Jul 21.
15 Autoimmune myelopathy associated with collapsin response-mediator protein-5 immunoglobulin G.Ann Neurol. 2008 Apr;63(4):531-4. doi: 10.1002/ana.21324.
16 Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.J Clin Microbiol. 1992 Feb;30(2):287-90. doi: 10.1128/jcm.30.2.287-290.1992.
17 Increased seroreactivity to human T cell lymphoma/leukemia virus-related endogenous sequence-1 Gag peptides in patients with human T cell lymphoma/leukemia virus myelopathy.AIDS Res Hum Retroviruses. 2015 Feb;31(2):242-9. doi: 10.1089/AID.2014.0171. Epub 2014 Nov 19.
18 Outcomes of Surgery for Thoracic Myelopathy Owing to Thoracic Ossification of The Ligamentum Flavum in a Nationwide Multicenter Prospectively Collected Study in 223 Patients: Is Instrumented Fusion Necessary?.Spine (Phila Pa 1976). 2020 Feb 1;45(3):E170-E178. doi: 10.1097/BRS.0000000000003208.
19 Enzymatic characterization of ELOVL1, a key enzyme in very long-chain fatty acid synthesis.Biochim Biophys Acta. 2015 Feb;1851(2):231-7. doi: 10.1016/j.bbalip.2014.12.005. Epub 2014 Dec 11.